Table 3.
Logistic analysis of Radscore and clinical features for evaluation of HAIC response in training cohort
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| P | HR (95% CI) | P | HR (95% CI) | |
| Gender (male/female) | 0.194 | 2.840 (0.586–13.746) | ||
| Age (y) (< 60/ ≥ 60) | 0.758 | 0.994 (0.958–1.031) | ||
| Maximum tumor size (> 100 mm/ ≤ 100 mm) | 0.909 | 0.944 (0.353–2.524) | ||
| BCLC stage (B/C) | 0.270 | 0.294 (0.033–2.584) | ||
| Tumor number (N) (1/ > 1) | 0.213 | 1.866 (0.698–4.983) | ||
| PVTT (none/I/II/III/IV) | 0.270 | 0.294 (0.033–2.584) | ||
| HBV/others | 0.989 | 0.775 (0.480–1.252) | ||
| Child–Pugh class (A/ B) | 0.869 | 0.894 (0.237–3.372) | ||
| DCP (≤ 1000/> 1000) | 0.264 | 0.647 (0.301–1.388) | ||
| ALT (≤ 40/> 40 U/L) | 0.088 | 2.706 (0.859–8.526) | ||
| AST (≤ 40/> 40 U/L) | 0.963 | 0.960 (0.164–5.607) | ||
| ALB (≤ 35 /> 35 g/L) | 0.155 | 2.666 (0.688–10.332)) | ||
| TBIL (≤ 20 /> 20 μmol/L) | 0.728 | 1.180 (0.461–3.022) | ||
| PT (≤ 13/> 13 s) | 0.438 | 0.686 (0.264–1.779) | ||
| AFP (≤ 20/20–200/ ≥ 200) | 0.264 | 0.647 (0.301–1.388) | ||
| ALBI score | 0.033 | 3.686 (1.104–12.300) | 0.024 | 2.140 (1.10–4.15) |
| Radscore | 0.005 | 130.95 (4.25–3644.14) | 0.004 | 124.45 (5.86–1347) |